Some germs survive because they're lucky. Acinetobacter survives because it's incredibly good at adapting. What Is Acinetobacter?Acinetobacter is a group of bacteria found naturally in the environment, including soil and water. While many species rarely cause disease, Acinetobacter baumannii has become an important opportunistic pathogen in healthcare settings.An opportunistic pathogen usually doesn't make healthy people sick but can cause serious infections when a person's immune system is weakened or when bacteria gain access to normally sterile parts of the body through surgery, medical devices, or injuries.Where Is It Found?Acinetobacter can be found in:Soil and waterHealthcare environments, where it can survive on surfaces and medical equipmentOn skin, in wounds, and in the respiratory, urinary, and digestive tracts without causing illness (called colonization)Who Is Most at Risk?Most healthy people are at low risk for developing an Acinetobacter infection. People at higher risk include those who:Have been hospitalized for an extended periodHave received care in an intensive care unit (ICU)Live in or have recently received care in a long-term acute care hospital (LTACH)Need a ventilator (breathing machine)Have a urinary catheter or central lineHave recently had surgeryHave chronic wounds or burnsHave weakened immune systemsHave received prolonged or multiple courses of antibioticsHave serious underlying medical conditionsWhat Infections Can It Cause?Acinetobacter can cause a variety of infections, especially in people receiving healthcare. Most infections occur when the bacteria enter a part of the body where they do not normally belong. Common infections include:Pneumonia, including ventilator-associated pneumonia (VAP)Bloodstream infections (bacteremia)Urinary tract infections (UTIs)Wound infectionsSurgical site infectionsMeningitis (less common)Why Do We Care?Acinetobacter is an important cause of healthcare-associated infections. It has been implicated in numerous hospital outbreaks because it can survive in healthcare environments and spread among vulnerable patients. Some strains have become multidrug-resistant (MDR), making infections more difficult to treat and limiting antibiotic treatment options. Continue LearningColonizationOpportunistic PathogenMultidrug Resistance (MDR)CRABHealthcare-Associated InfectionsContact PrecautionsTrusted ResourcesAbout AcinetobacterCRAB Acinetobacter baumanniiBest Practices for Environmental Cleaning for Prevention and Control of Infections in All Health Care Settings, 3rd EditionWHO warns of widespread resistance to common antibiotics worldwideWHO Bacterial Priority Pathogens List, 2024Hospital outbreak of Carbapenem-resistant acinetobacter baumannii in the context of local facility transmissionDifferentiation Between Acinetobacter Baumannii Colonization and Infection and the Clinical Outcome Prediction by Infection in Lower Respiratory TractClinical and Pathophysiological Overview of Acinetobacter Infections: a Century of ChallengesAcinetobacter baumannii: much more than a human pathogenAcinetobacter baumannii treatment strategies: a review of therapeutic challenges and considerations

Antimicrobial resistance occurs when microorganisms develop or acquire the ability to survive exposure to an antimicrobial drug that would normally inhibit or kill them. For bacteria, this is commonly referred to as antibiotic resistance.Why It MattersResistance can make infections harder to treat and may lead to:fewer effective treatment optionslonger illnesses or hospital staysuse of more toxic or expensive drugsincreased risk of complicationsspread of resistant organisms within healthcare settings and communitiesExample:A strain of E. coli that produces an ESBL may be resistant to many commonly used beta-lactam antibiotics, limiting treatment options.One Important DistinctionResistance can be intrinsic or acquired.Some organisms are naturally resistant to certain antimicrobials, while others acquire resistance through mutation or resistance genes.IP PearlEvery unnecessary antimicrobial exposure creates selective pressure that can favor resistant organisms. Antimicrobial stewardship and infection prevention work together: one reduces unnecessary drug pressure, and the other helps stop resistant organisms from spreading.Related Terms:Antimicrobial StewardshipDe-escalationBroad-Spectrum AntibioticNarrow-Spectrum AntibioticSusceptibility Testing

Antimicrobial stewardship is the coordinated effort to use antibiotics and other antimicrobial medications only when they are needed and in the most appropriate way. The goal is to choose the right drug, dose, route, and duration while still treating the infection effectively.Why It MattersGood antimicrobial stewardship helps:improve patient outcomesreduce unnecessary antibiotic exposurelower the risk of C. difficilereduce adverse drug effectsslow the development of antimicrobial resistanceExample:A patient is started on broad-spectrum antibiotics for suspected sepsis. Once cultures identify the organism and susceptibility results are available, the care team narrows therapy and shortens the duration to what is clinically appropriate. That is antimicrobial stewardship in action.One Important DistinctionAntimicrobial stewardship is not simply about using fewer antibiotics. It is about using antimicrobials more appropriately.Sometimes that means stopping treatment.Sometimes it means narrowing therapy.Sometimes it means changing the dose or route.And sometimes it means making sure the patient receives the right antibiotic quickly.IP PearlThe goal is not:“Use less antibiotics.”The goal is:“Use the right antimicrobial, for the right patient, at the right dose, for the right amount of time.”Related Terms:Empiric TherapyDefinitive TherapyDe-escalationBroad-Spectrum AntibioticNarrow-Spectrum AntibioticIV-to-PO ConversionSelective Pressure

Antimicrobial susceptibility testing (AST) is a test performed in the microbiology laboratory used to determine whether a microorganism is likely to be susceptible, intermediate, or resistant to specific antimicrobial drugs. The results help clinicians choose therapy that is more likely to work against the organism causing the infection.Why It MattersAST helps move treatment from educated guesswork to more targeted therapy.It can support:de-escalationdefinitive therapydetection of resistant organismsavoidance of ineffective antibioticsantimicrobial stewardshipExample:A blood culture grows E. coli. AST shows that the isolate is susceptible to ceftriaxone but resistant to ciprofloxacin. Those results help guide the treatment choice.One Important DistinctionA susceptibility result does not automatically mean a drug is the best clinical choice. The site of infection, drug penetration, patient factors, dosing, and resistance mechanisms still matter.IP PearlAST tells you what the organism looks susceptible to in the laboratory. Clinical treatment still requires putting that result into context.Related Terms:Definitive TherapyDe-escalationAntimicrobial ResistanceAntimicrobial Stewardship